Freyr - 15.12.2004, Side 38

Culicoides. Res. in Vet. Science
47:283-287.
7) Anderson G.S., Belton P., Kleider
N., (1993). Hypersensitivity of
horses in British Columbia to
extracts of native and exotic
species of Culicoides (Diptera:
Ceratopogonidae). J. Med.
Entomol. 30:657-663.
8) Wilson A.D., Harwood L.J.,
Björnsdottir S., Marti E., Day
M.J., (2001). Detection of IgG
and IgE serum antibodies to
Culicoides salivary gland anti-
gens in horses with insect dermal
hypersensitivity (sweet itch).
Equine Vet J. 33:707-13.
9) Hudson A., Bowman L., Orr
C.W.M. (1960). Effects of
absence of saliva on blood feed-
ing by mosquitoes Science
131:1730-31.
Moli
Nautariðukreppan
VARÐ KANADÍSKUM
BÆNDUM DÝR
Nautariðan, sem greindist í
Kanada árið 2003, hefur fram að
þessu kostað kanadískan land-
búnað um 3,2 milljarða evra en
tekjur kanadískra bænda lækk-
uðu um þriðjung á árinu 2003.
Á fyrri hluta árs 2004 lækk-
uðu þær síðan enn um 30%
meðan beðið var eftir að önnur
lönd opnuðu markaði sína aftur
fyrir kanadískt nautakjöt.
Kreppan hófst í maí 2003,
þegar kúariða greindist í naut-
grip í Alberta fylki. Um þrjátíu
lönd, þar á meðal Bandaríkin
lokuðu þá fyrir innflutning á
kanadísku nautakjöti. Banda-
ríkin banna enn innflutning á
lifandi nautgripum frá Kanada
sem eru eldri en 30 mánaða.
(Landsbygdens Folk
nr. 50/2004).
10) Peng Z., Hongbing L., Simons
F.E., (1998). Immunoblot analysis
of salivary allergens in 10 mosqui-
to species with worldwide distrib-
ution and the human IgE respons-
es to these allergens. J. Allergy
Clin. Immunol. 101:498-505
11) Racioppi J.V., & Stielman A.,
(1987). Secretory proteins from
the salivary glands of adult Aedes
aegypti mosquitoes. Insect.
Biochem. 17:503-511
12) Peng Z., Yang J., Hongbing L.,
Simons F.E., (1999). Production
and characterization of mono-
clonal antibodies to two new mos-
quito Aedes aegypti salivary pro-
teins. Incect Bioch. and Mole-
cular Biol. 29:909-914
13) Estelle F., Simons R., Peng Z.,
(2001). Mosquito allergy:
Recombinant mosquito salivary
antigens for new diagnostic tests.
Int. Arch. Allergy Immunol.
124:403-405
14) Vrtala S„ Akdis C.A., Budak F„
Akdis M., Blaser K., Kraft D„
Valenta R„ (2000). T cell epitope-
containing hypoallergenic recom-
binant fragments of the major
birch pollen allergen, Bet v 1,
induce blocking antibodies. J.
Immunol. 165:6653-6659
15) Crameri R„ (1998). Recombinant
Aspergillus fumigatus allergens:
From the nucleotide sequnces to
clinical applications. Inr. Arch.
Allergy Immunol. 115:99-114.
16) Ichikaw K„ Vailes L.D., Pomés
A„ Chapman M.D., (2001).
Identification of a novel cat aller-
gen - cystatin. Int. Arch. Allergy
Immunol. 124:55-56
17) Muller, U.,R. (2002) Re-
combinant Hymenoptera venom
allegens. Allergy 57: 570-576.
18) Schmidt M„ & Hoffman D.R.,
(2002). Expression systems for
production of recombinant aller-
gens. Int. Arch. Allergy Immunol.
128:264-270
19) Wayne R.T., Smith W„ Hales
B.J., Mills K.L., Brien R.M.O.,
(2002). Characterization and
immunobiology of house dust
mite allergens. Int. Arch. Allergy
Immunol. 129:1-18.
20) Soldatova L.N., Crameri R„
Gmachl M„ Kemeny D.M.,
Schmidt M„ Weber M„ Mueller
U.R., (1998). Superior biologic
activity of the recombinant bee
venom allergen hyaluronidase
expressed in baculovirus-infected
insect cells as compared with
Escherichia coli. J. Allergy Clin.
Immunol. 101:691-698.
21) Crossen, R„ Gruenwals, S. (1997)
Baculovirus, Expression Vector
System, Pharmingen Instruction
Manual 4th. ed
22) Schmidt M„ McConnell T.J.,
Hoffman D.R., (1996). Production
of a recombinant imported fíre ant
venom allergen, Sol i 2, in native
and immunoreactive form. J.
Allergy Clin. Immunol. 98:82-88.
23) Althaus H„ Muller N„ Crameri R„
Peveri P„ Busato A„ Mellor P„
Torsteinsdottir S„ Marti E. Cloning
and sequencing of a cDNA
expressing a ribosomal P0 peptide
from Culicoides nubeculosus
(Diptera). (2004) Vet. Immunol.
Immunopathol. 99:99-111.
24) Valenta, R. and Kraft, D. (2002)
From allergen structure to new
forms of allergen -specifíc
immunotherapy. Curr. Op.
Immunol. 14:718-727.
25) Canonica, G.W. and Passalacqua,
G. (2003) Noninjection routes for
immunotherapy. J.Allergy Clin.
Immunol. 111:437-448.
26) Nelson, H.S. (2003) Advances in
upper airway diseases and allegen
immunotherapy. J. Allergy Clin.
Immunol. 111:793-798.
27) Nilsen, K. (1984) Kompendium i
intem medicin 2:332-333.
28) Romagnani S. (2000) T-cell sub-
sets (Thl versus Th2). Annals of
Allergy, Asthma, and Immuno-
logy 85:9-18.
| 38 - Freyr 11-12/2004